Appendix S1. List of Figures. List of Tables

Similar documents
Prediction of Mortality Using On-Line, Self-Reported Health Data: Empirical Test of the Realage Score

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

Vascular Diseases. Overview: Selected Slides

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

CVD Prevention, Who to Consider

Risk modeling for Breast-Specific outcomes, CVD risk, and overall mortality in Alliance Clinical Trials of Breast Cancer

Statins in lung disease

Present value cost-savings to Medicaid over 25 years

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE

Biostatistics and Epidemiology Step 1 Sample Questions Set 1

Technical Appendix I26,I27.1,I28,I43-45,I47.0- I47.1,I47.9,I48,I ,I51.0- I51.4,I52,I77-I84,I86-I97,I98.1-I98.8,I99

Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures

2013 Hypertension Measure Group Patient Visit Form

CARDIOVASCULAR HEALTH LIVING A HEART HEALTHY LIFE. Matt Handley MD Group Health Physicians

Non communicable Diseases in Egypt and North Africa

EuroPrevent 2010 Fatal versus total events in risk assessment models

Archimedes, Medicare, and ARCHeS

Leading Causes of Death in US (2013-CDC):

CONTRIBUTING FACTORS FOR STROKE:

How would you manage Ms. Gold

HORMONE REPLACEMENT THERAPY

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Because we care about your health

Albany County Health Profile

The ACCELERATE Trial

Evaluating the Efficacy and Service User Perceptions of a Preventive CVD Risk Assessment

Supplemental tables/figures

Frequently asked questions in response to ABC Catalyst report about cholesterol and medications

The Burden of Tobacco, Tobacco Control, and Advocacy: Policy Strategies for Oral Health. Robert McMillen, PhD

Diabetes MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; HENRY N. GINSBERG, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR; CHING-LING CHEN, PhD, WRITER

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

The Framingham Coronary Heart Disease Risk Score

RESEARCH. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Joshua Shepherd PA-C, MMS, MT (ASCP)

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study

Comparability of patient-reported health status: multi-country analysis of EQ-5D responses in patients with type 2 diabetes

Cardiovascular Risk Assessment and Management Making a Difference

To fully participate in this session: Please obtain a Framingham Risk Calculator google: My Health Alberta Risk Calculator click: Heart Disease Risk

CVD risk assessment using risk scores in primary and secondary prevention

RESEARCH. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2

AHA Clinical Science Special Report: November 10, 2015

C1 Qu2 DP2 High levels of preventable chronic disease, injury and mental health problems - CVD

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study

The Clinical Unmet need in the patient with Diabetes and ACS

Supplementary Appendix

QStatin Update Information

Epidemiologic Measure of Association

Supplementary Online Content

THE SAFETY CHECK LIST BEFORE STARTING HT

well-targeted primary prevention of cardiovascular disease: an underused high-value intervention?

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

Wine, Alcohol, and Cardiovascular Health: Revisiting the Health Benefits of Wine in the Framingham Heart Study. Michael Darden and Douglas Nelson

Placebo-Controlled Statin Trials

Appendix: Supplementary tables [posted as supplied by author]

Using Coronary Artery Calcium Score in the Quest for Cardiac Health. Robert J. Hage, D.O.

Supplementary Online Content

Community Health Needs Assessment for UI Health Hospital & Clinics

Plasma Lipids and Global Cardiovascular Risk

Prevalence of Cardiac Risk Factors among People Attending an Exhibition

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

Articles. Funding Medical Research Council, National Institute for Health Research, and Wellcome Trust.

BIOLOGICAL D E T E R M I N AN T S O F H E AL T H ( )

Heart Disease and Stroke Statistics 2010 Update. 2009, American Heart Association. All rights reserved.

Cigarettes. Ada Ellisman, Bryan Gibson, & Evie White

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Body-mass index and cause-specific mortality in adults: collaborative analyses of 57 prospective studies

1. Coronary heart disease is a major cause of death in the western world.

Tobacco The totally avoidable risk factor of cardiovascular disease. Dr Vash Mungal-Singh

the standard deviation (SD) is a measure of how much dispersion exists from the mean SD = square root (variance)

Antihypertensive Trial Design ALLHAT

The Economic Burden of Hypercholesterolaemia

Study 2 ( ) Pivotal Phase 3 Study Top-Line Results. October 29, 2018

Supplementary Online Content

Dread Disease Insurance towards local experience

COMPETING INTEREST OF FINANCIAL VALUE

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Tobacco Cessation for People with Disabilities. Christopher M. Anderson 2011 Disability and Health Partners Meeting June 14 16, 2011

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

The Impact of Smoking on Acute Ischemic Stroke

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Correlation of novel cardiac marker

Logistic Regression Predicting the Chances of Coronary Heart Disease. Multivariate Solutions

Supplementary Table S1: Proportion of missing values presents in the original dataset

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

Smoke free medium and high density housing is it achievable?

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

Chapter 6: Combined Cardiovascular Risk Factors

Employee Name: Male Female Employee Personnel Number: T# Date of Birth / / Age Employee Referred by Name:

The Metabolic Syndrome: Is It A Valid Concept? YES

CONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7

RESEARCH. Dagfinn Aune, 1,2 Abhijit Sen, 1 Manya Prasad, 3 Teresa Norat, 2 Imre Janszky, 1 Serena Tonstad, 3 Pål Romundstad, 1 Lars J Vatten 1

Transcription:

Appendix S1 List of Figures S1 Comparison of death rates in RealAge sample to US death rates...................... 1 S2 RealAge delta in California sample with full identifiers.......................... 2 S3 RealAge delta in RealAge population.................................... 3 S4 RealAge delta in California sample with full identifiers - age 25 to 44.................. 5 S5 RealAge delta in California sample with full identifiers - age 45 to 64.................. 7 S6 RealAge delta in California sample with full identifiers - age 65 to 84.................. 9 S7 Calibration plot - Age............................................ 12 S8 Calibration plot - RealAge.......................................... 13 S9 Calibration plot - Framingham........................................ 14 S10 Calibration plot - Framingham (unscaled age)............................... 15 S11 Calibration plot - Framingham (unscaled age, indicators only)...................... 16 S12 Comparison of RealAge score distributions for all deceased/surviving users and deceased/surviving "healthy" users (heart disease)........................................ 21 S13 Comparison of RealAge score distributions for all deceased/surviving users and deceased/surviving "healthy" users (cancer)........................................... 23 S14 Comparison of RealAge score distributions for all deceased/surviving users and deceased/surviving "healthy" users (external causes)...................................... 25 List of Tables S1 25 to 44 - causes of death.......................................... 4 S2 45 to 64 - causes of death.......................................... 6 S3 65 to 84 - causes of death.......................................... 8 S4 Log-Likelihood for Table 4 Comparison of Age and RealAge....................... 10 S5 Framingham Hard Coronary Heart Disease 10-Year Risk Model results unscaled age.......... 11 S6 Framingham Hard Coronary Heart Disease 10-Year Risk Model results indicators only, unscaled age. 11 S7 25 to 44 - model results........................................... 17 S8 25 to 44 - model results (age base)..................................... 17 S9 45 to 64 - model results........................................... 18 S10 45 to 64 - model results (age base)..................................... 18 S11 65 to 84 - model results........................................... 19 S12 65 to 84 - model results (age base)..................................... 19 S13 All users - Death from Heart Disease.................................... 20 S14 Death from Heart Disease (age in base hazard)............................... 20 S15 All users - Death from Cancer....................................... 22 S16 Death from Cancer (age in base hazard).................................. 22 S17 All users - Death from External Cause................................... 24 S18 Death from External Cause (age in base hazard).............................. 24 S19 All users - at least two years follow-up................................... 26 S20 All users - Death from Heart Disease, no Report Diagnosis or Interest for Heart Attack or Stroke, no Smoking................................................... 27 S21 All users - Death from Cancer, no Reported Diagnosis or Interest for Cancer, no Smoking........ 27 S22 All users - Death from External Cause, no Reported Diagnosis or Interest for Depression........ 28 0

Comparison to US Death Rates Comparison of Death Rates Realge US Deaths per 100,000 0 1000 2000 3000 4000 5000 Deaths in RealAge California data Deaths in US 30 40 50 60 70 80 Age Figure S1: Comparison of death rates in RealAge sample to US death rates. 1

Distribution of RealAge delta RealAge delta in California sample with full identifiers (190,000) Density 0.00 0.02 0.04 0.06 30 20 10 0 10 20 30 RealAge delta Figure S2: RealAge delta in California sample with full identifiers 2

RealAge delta in RealAge population (10 million only) Frequency 0e+00 2e+05 4e+05 6e+05 8e+05 1e+06 30 20 10 0 10 20 30 RealAge delta Figure S3: RealAge delta in RealAge population 3

Causes of death and RealAge delta by age group 25 to 44 Table S1: 25 to 44 - causes of death Cause of Death Count Follow-Up Mean Follow-Up Median External Causes 46 938.5 767 Cancer 21 1074 948 Heart Disease 16 1307.4 1041 # of users in sample 74,965 # deceased in sample 118 4

RealAge delta in California sample with full identifiers (age 25 to 44) Deceased Density 0.00 0.02 0.04 0.06 0.08 30 20 10 0 10 20 30 RealAge delta Figure S4: RealAge delta in California sample with full identifiers - age 25 to 44 5

45 to 64 Table S2: 45 to 64 - causes of death Cause of Death Count Follow-Up Mean Follow-Up Median Cancer 161 1215.3 980 Heart Disease 115 970.4 779 External Causes 48 935.5 739 Chronic Lower Respiratory 29 993.2 887 # of users in sample 91,886 # deceased in sample 479 6

RealAge delta in California sample with full identifiers (age 45 to 64) Density 0.00 0.01 0.02 0.03 0.04 0.05 0.06 0.07 Deceased 30 20 10 0 10 20 30 RealAge delta Figure S5: RealAge delta in California sample with full identifiers - age 45 to 64 7

65 to 84 Table S3: 65 to 84 - causes of death Cause of Death Count Follow-Up Mean Follow-Up Median Cancer 157 1016.8 867 Heart Disease 121 1034 897 Chronic Lower Respiratory 29 1018.4 879 Cerebrovascular Disease 26 1120 1028.5 # of users in sample 21,847 # deceased in sample 449 8

RealAge delta in California sample with full identifiers (age 65 to 84) Density 0.00 0.01 0.02 0.03 0.04 0.05 0.06 Deceased 30 20 10 0 10 20 30 RealAge delta Figure S6: RealAge delta in California sample with full identifiers - age 65 to 84 9

Log-Likelihood for Table 4 Comparison of Age and RealAge Table S4: Log-Likelihood for Table 4 Comparison of Age and RealAge Model.1 Log.Likelihood Age -11176.1798, -10698.1112 Model.2 Log.Likelihood chisq.df.p.value RealAge -10698.1112-10416.2891 563.6442, 0, 0 Model.3 Log.Likelihood chisq.df.p.value Age.and.RealAge.Delta -10416.2891-10414.563 3.4523, 1, 0.0632 10

Framingham Risk Factor Estimates Table S5: Framingham Hard Coronary Heart Disease 10-Year Risk Model results unscaled age Age 1.073 (1.054, 1.092) 0.000 Current Smoker 4.218 (2.858, 6.221) 0.000 Blood Pressure (points) 1.266 (1.062, 1.510) 0.008 Cholesterol (points) 0.903 (0.789, 1.033) 0.136 HDL Cholesterol (points) 1.202 (0.961, 1.504) 0.108 Table S6: Framingham Hard Coronary Heart Disease 10-Year Risk Model results indicators only, unscaled age Age 1.081 (1.064, 1.097) 0.000 Current Smoker 4.263 (2.889, 6.290) 0.000 Blood Pressure 1.567 (1.085, 2.264) 0.017 Cholesterol 0.732 (0.494, 1.085) 0.121 11

Calibration plots Age Fraction Surviving 5 Years 0.988 0.990 0.992 0.994 0.996 0.998 1.000 0.986 0.988 0.990 0.992 0.994 0.996 0.998 1.000 Predicted 5 Year Survival Figure S7: Calibration plot - Age. 12

RealAge Fraction Surviving 5 Years 0.96 0.97 0.98 0.99 1.00 0.96 0.97 0.98 0.99 1.00 Predicted 5 Year Survival Figure S8: Calibration plot - RealAge. 13

Framingham Fraction Surviving 5 Years 0.988 0.990 0.992 0.994 0.996 0.998 1.000 0.988 0.990 0.992 0.994 0.996 0.998 1.000 Predicted 5 Year Survival Figure S9: Calibration plot - Framingham. 14

Framingham (unscaled age) Fraction Surviving 5 Years 0.97 0.98 0.99 1.00 0.96 0.97 0.98 0.99 1.00 Predicted 5 Year Survival Figure S10: Calibration plot - Framingham (unscaled age) 15

Framingham (unscaled age, indicators only) Fraction Surviving 5 Years 0.96 0.97 0.98 0.99 1.00 0.96 0.97 0.98 0.99 1.00 Predicted 5 Year Survival Figure S11: Calibration plot - Framingham (unscaled age, indicators only) 16

Estimates by age group 25 to 44 Table S7: 25 to 44 - model results Age 1.054 (1.021, 1.087) 0.001 RealAge 1.081 (1.066, 1.095) 0.000 Age 1.049 (1.017, 1.082) 0.002 RealAgeDelta 1.087 (1.073, 1.102) 0.000 Table S8: 25 to 44 - model results (age base) RealAgeDelta 1.087 (1.071, 1.103) 0.000 17

45 to 64 Table S9: 45 to 64 - model results Age 1.068 (1.050, 1.085) 0.000 RealAge 1.088 (1.079, 1.096) 0.000 Age 1.064 (1.047, 1.082) 0.000 RealAgeDelta 1.094 (1.085, 1.103) 0.000 Table S10: 45 to 64 - model results (age base) RealAgeDelta 1.095 (1.084, 1.105) 0.000 18

65 to 84 Table S11: 65 to 84 - model results Age 1.081 (1.064, 1.100) 0.000 RealAge 1.074 (1.064, 1.083) 0.000 Age 1.086 (1.067, 1.104) 0.000 RealAgeDelta 1.070 (1.059, 1.081) 0.000 Table S12: 65 to 84 - model results (age base) RealAgeDelta 1.071 (1.060, 1.082) 0.000 19

Heart Disease Estimates Table S13: All users - Death from Heart Disease Age 1.088 (1.077, 1.099) 0.000 RealAge 1.096 (1.087, 1.105) 0.000 Age 1.088 (1.077, 1.100) 0.000 RealAgeDelta 1.105 (1.092, 1.119) 0.000 # of users in sample 187,904 # deceased in sample 252 Table S14: Death from Heart Disease (age in base hazard) RealAgeDelta 1.109 (1.095, 1.123) 0.000 20

RealAge delta in California sample with full identifiers Density 0.00 0.02 0.04 0.06 0.08 Deceased (Heart Disease) No heart attack/stroke diagnosis or interest, no smoking 30 20 10 0 10 20 30 RealAge delta Figure S12: Comparison of RealAge score distributions for all deceased/surviving users and deceased/surviving "healthy" users (heart disease). 21

Cancer Estimates Table S15: All users - Death from Cancer Age 1.094 (1.084, 1.103) 0.000 RealAge 1.079 (1.071, 1.085) 0.000 Age 1.094 (1.084, 1.103) 0.000 RealAgeDelta 1.054 (1.042, 1.067) 0.000 # of users in sample 187,991 # deceased in sample 339 Table S16: Death from Cancer (age in base hazard) RealAgeDelta 1.051 (1.039, 1.064) 0.000 22

RealAge delta in California sample with full identifiers Density 0.00 0.02 0.04 0.06 0.08 Deceased (Cancer) No cancer diagnosis or interest, no smoking 30 20 10 0 10 20 30 RealAge delta Figure S13: Comparison of RealAge score distributions for all deceased/surviving users and deceased/surviving "healthy" users (cancer). 23

External Cause Estimates Table S17: All users - Death from External Cause Age 0.996 (0.980, 1.012) 0.584 RealAge 1.024 (1.010, 1.038) 0.000 Age 0.992 (0.976, 1.008) 0.348 RealAgeDelta 1.090 (1.070, 1.108) 0.000 # of users in sample 187,741 # deceased in sample 89 Table S18: Death from External Cause (age in base hazard) RealAgeDelta 1.087 (1.063, 1.111) 0.000 24

RealAge delta in California sample with full identifiers Density 0.00 0.02 0.04 0.06 0.08 Deceased (External Cause) No depression diagnosis or interest 30 20 10 0 10 20 30 40 RealAge delta Figure S14: Comparison of RealAge score distributions for all deceased/surviving users and deceased/surviving "healthy" users (external causes). 25

Estimates for users with at least two years of follow-up Table S19: All users - at least two years follow-up Age 1.079 (1.073, 1.085) 0.000 RealAge 1.080 (1.075, 1.084) 0.000 Age 1.078 (1.071, 1.085) 0.000 RealAgeDelta 1.081 (1.074, 1.090) 0.000 # of users in sample 160,261 # deceased in sample 642 26

Estimates for "healthy" users Table S20: All users - Death from Heart Disease, no Report Diagnosis or Interest for Heart Attack or Stroke, no Smoking Age 1.071 (1.046, 1.097) 0.000 RealAge 1.085 (1.063, 1.107) 0.000 Age 1.076 (1.050, 1.102) 0.000 RealAgeDelta 1.103 (1.070, 1.137) 0.000 # of users in sample 84,190 # deceased in sample 40 Table S21: All users - Death from Cancer, no Reported Diagnosis or Interest for Cancer, no Smoking Age 1.108 (1.083, 1.132) 0.000 RealAge 1.071 (1.054, 1.088) 0.000 Age 1.108 (1.083, 1.132) 0.000 RealAgeDelta 1.004 (0.968, 1.041) 0.847 # of users in sample 71,271 # deceased in sample 52 27

Table S22: All users - Death from External Cause, no Reported Diagnosis or Interest for Depression Age 0.992 (0.965, 1.020) 0.594 RealAge 1.010 (0.985, 1.035) 0.440 Age 0.991 (0.963, 1.019) 0.509 RealAgeDelta 1.066 (1.019, 1.115) 0.005 # of users in sample 124,919 # deceased in sample 27 28